135
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CAM, eCAM, Bioprospecting: The 21st Century Pyramid

      editorial
      Evidence-based Complementary and Alternative Medicine
      Oxford University Press

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CAM and a Challenging Pyramid Pyramids touch us in many ways. According to a popular definition which most of us will understand, a pyramid is a stone structure with a flat (usually) square base and with sloping sides that meet at the top, especially built by the ancient Egyptians as a tomb or by the Aztecs and Mayas as a platform for a temple, raised for edification. Then there are food pyramids that propose to solve the obesity epidemic. How does such a definition fit within the confines of complementary and alternative medicine (CAM), eCAM and bioprospecting? What is more, how do we move the ancient and familiar definition to signify the 21st century pyramid and one that is relevant to CAM? At the moment, I do not yet have data on the ancient practices of the Egyptians nor the Aztecs and Mayas as their approaches relate to CAM or to eCAM. We do know about historical practices of similar ages in history from Japan and Taiwan, just to cite two recent examples of rigorous presentations (1,2). The relevant CAM pyramid that I will detail could continue to be a hard impenetrable structure unless we are willing to in effect dismantle it, to deconstruct it from bottom up from those points that gird it to unfavorable approaches that are less acceptable in the evidence-based approach to CAM. A pyramid has recently been published in Nature Immunology entitled: ‘Complementary and alternative medicine: assessing the evidence for immunological benefits’ (3). In this pyramid, there is a hierarchy of evidence. Information regarding the efficacy and safety of any clinical approach, including those of CAM, spans a continuum that ranges at the base all the way to the peak or the pyramid's point, from anecdotes and retrospective studies to small randomized, controlled trials (phase II clinical trials) and large randomized, controlled trials (phase III clinical trials). In my opinion, this paper and its contents, and the pyramid represent a seminal tribute to the role of the immune system in CAM. NCCAM and CAM At the national level CAM is becoming increasingly more prominent in the scientific establishment especially in immunology (3). There seems to be a focus on the innate immune system especially the ubiquitous natural killer (NK) cells (4,5). In terms of a comparative coverage of NK cells and CAM, clearly that by Takeda and Okumura (4) is more recent, thorough and extensive. Two of the tables, for example, cover the known NK receptors and NK activation inducing CAM. Some of the figures are equally informative and elegant. Figure 1, for instance, treats NK cells in tumor surveillance, relationships to cytokines and the critical role they play in the inhibition of angiogenisis by tumor development. In Figure 3, there is an all-encompassing coverage of immune system control by the autonomic nervous system where there is depicted the intimate cross-talk between NK cells and their control by the autonomic nervous system. In 1998, the National Center for Complementary and Alternative Medicine (NCCAM) was established by the US Congress at the National Institutes of Health (Bethesda, MD) to investigate CAM modalities rigorously in order to determine which are beneficial and worthy of further consideration for mainstream practice. Among the many CAM approaches that warrant careful investigation are those that claim to sustain, restore or boost immunity. In this review, Goldrosen and Strauss (3) covered the following topics: use of CAM, regulation of CAM, risks of CAM use, clinical trials of CAM, CAM and immunity, dietary supplements and mind–body approaches. In Table 1, they cover some ongoing, large phase III trials of CAM modalities; in Table 2 some CAM modalities that might mediate their effects through the immune system; and in Table 3 some herbal products that modulate immune responses. Their Box 1 warns of the challenges of conducting clinical trials of CAM. Figure 1 treats CAM domains and some of the most common examples; a glossary that defines nearly 20 such CAM practices. What about the aforementioned CAM pyramid? Depicted in Figure 2 there is a hierarchy of evidence. This CAM pyramid begins at the base with the least desirable of approaches such as anecdotes and case studies which eCAM is being careful not to publish unless backed by strong evidence and clear indications of a scientific approach (6). Chemists, CAM and Kampo This is more from the viewpoint of the biologist. Now it seems that chemists are becoming involved in this international CAM movement. Even popular coverage is an everyday occurrence (7,8). Recently Professor Haruki Yamada, a member of the Editorial Board of eCAM, informed me of his invitation to lecture at a recent meeting of the American Chemical Society held in San Diego, CA. Of enormous special interest for CAM in general and of course eCAM was the American Chemical Society's Newsletter (9). In it there is substantial credit offered to the entire sweep of CAM. Topics included: what is CAM, the top 10 CAMs, how can chemists help? CAM chemical prospecting and drawing a baseline. It is obvious why Professor Yamada was appropriate as an invited participant at this meeting because of his own work that promises an approach to CAM using the evidence-based approach and which has a distinct analytical chemical orientation. According to Yamada (10) ‘the efficacy of Kampo medicines cannot be explained by the pharmacological activity of just one active ingredient, and several active ingredients may affect the immune, endocrine, and neural systems of the whole body by several combination effects such as synergistic and or antagonistic effects’. Some of these active ingredients also work through structural modifications to the actual active compounds by endogenous factors such as intestinal bacteria or gastric juice. Because standardization of natural medicine is very important, indicator compounds, hopefully active ingredients should control and fingerprint it using three-dimensional HPLC. Analysis of pharmacological activity related to clinical effects by in vitro and in vivo biological methods might also be very important to obtain reproducible effects of herbs. In one important figure, a three-dimensional HPLC pattern of one Kampo formula, Juzen-taiho-to (SI-Quan-Da-Bu-Tang in Chinese), is shown. Juzen-taiho-to has been used for the treatment of patients recovering from surgery or suffering from diseases by promoting the improvement of their debilitated general condition. Juzen-taiho-to also has been administered to patients with anemia or anorexia. The clinical effects observed suggest that the formula enhances immune responses and improves the functioning of the hematopoietic systems. Since it is possible to prepare HPLC fingerprinting patterns based on the composition of the constituents in each formula, this method is useful for the standardization of not only Kampo medicines but also natural medicines. Now let us put together the two approaches: biologists (immunological focus of Goldrosen and Strauss) and those of the chemists (Kampo of Yamada) and bioprospecting (Muller and Cooper). As mentioned earlier and as the following reports will confirm, there is a preponderance of focus and emphasis on plants and little or no coverage of natural products from animals. Yet there is ample evidence as we have published recently (5,12–14). Thus bioprospecting is a new frontier for CAM! Bioprospecting: Invertebratres and Natural Products From Muller's extensive work, we see a compendium of excellent very supportive work for the real existence of useful products from animals. Examples of compounds that are already in medical use [inhibition of tumor/virus growth (arabinofuranosyl cytosine and arabinofuranosyl adenine)], or are being considered as lead structures [acting as cytostatic and anti-inflammatory secondary metabolites (avarol/avarone), causing induction of apoptosis (sorbicillactone)] or as prototypes for the interference with metabolic pathways common in organisms ranging from sponges to humans [modulation of pathways activated by fungal components (aeroplysinin), inhibition of angiogenesis (2-methylthio-1,4-napthoquinone), immune modulating activity (FK506)] are discussed in this study. In addition, bioactive proteins from sponges are listed [antibacterial activity (pore-forming protein and tachylectin)]. Finally, it is outlined that the skeletal elements—the spicules—serve as blueprints for new biomaterials, especially those based on biosilica, which might be applied in biomedicine. These compounds and biomaterials have been isolated/studied by members of the German Center of Excellence BIOTECmarin. CAM and Earthworm Natural Products The citation of this prime example of what bioprospecting has yielded has been derived from careful analyses of products synthesized and secreted by sponges that are multicellular members of the second animal phylum by classification, the Porifera. If we turn now to more complex multicellular species where there is an enormous amount of information that is several centuries old, witness the literature pertaining to the earthworm's healing properties (15). Earthworm lytic molecules are antimicrobial and may prove useful as antibacterial agents and prophylatic molecules, an idea that is not far fetched since the discovery of antibiotics was serendipitous. Two molecules, lysenin and eiseniapore, depend to some extent on intracellular lipid trafficking mechanisms. In fact, trafficking dysfunction leads to disease development, such as Tangier disease and Neumann–Pick disease type C, or contributes to the pathogenesis of diseases such as Alzheimer disease and atherosclerosis. Lysenin reacts specifically with fibroblast membranes from patients with Niemann–Pick disease, a rather curious finding, but one that may have some clinical relevance (16). Thus specific binding of lysenin to sphingomyelin on cellular membranes may prove to be a useful tool to probe the molecular motion and function of sphingomyelin in biological membranes, especially in an effort to explain the mechanism of lysis in earthworms. These results stress the need for concerted analyses of various lytic pathways that may be mediated by the earthworm immunodefense system. Both the products of sponges and those of other animals are of potential importance as great as those being exploited from plants. The goal for the future is successfully to introduce some of these compounds in the treatment of human diseases in order to raise public awareness on the richness and diversity of natural products that could be carefully harvested for the benefit of mankind. This is an example where the scientific approach presents solid evidence that certain molecules are ready for testing. CAM and an Informative Triangle: A New Pyramid Since for many scientists, entering the world of CAM has challenged long-established ways of looking at the world, I propose that for a moment we look at the pyramid in yet another way and watch as it transforms itself into a triangle. In its new form, the hierarchy disappears and we can see the balance of three separate elements and the relationships between these parts. The triangle delineates the balance that is at the core of many holistic medicines. One example of this is Olalde's triangle of health, introduced in our last issue of eCAM. He describes the triangle as a ‘governing dynamic, that survival potential of any living system depended on enhancing the three constituents that structure its common denominator. These essential factors are energy, intelligence and organization—three sided but with no layering from bottom up. His hypothesis under this scope proposes that the survival potential (health) of every human being could be improved by a synergetic increase of any or all of these three factors because they were interdependent (17). To paraphrase Olalde, the basis for the hypothesis was the premise that the triangle's integrity constituted a reflection of the entropic status of the organism. This could then be enhanced by providing survival energy and information to the cells, furnishing negative entropy from herbs, to create an endogenous healing tendency within the body—called syntropy. This new view of an ancient structure points to an essential quality of scientific research, especially in the varied world of CAM: the ability to see the objects of our study as if we are seeing them for the first time. By so doing, we are able to re-think theories and hypotheses that have been long accepted, and have the courage to embark on a new search that will eventually lead to new and exciting healing modalities with a firm evidence base.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Complementary and Alternative Medicine, When Rigorous, can be Science

          Early Beginnings in China In October 2003, during the 12th Congress of Oriental Medicine in Taipei, the National Palace Museum organized an enormously pertinent exhibit in Gallery 313 derived largely from the museum's collection of ancient medical texts that includes classics on numerous topics. It is entitled Life is Worth More than Gold: A Special Exhibition of Ancient Medicinal Classics. In the English translation of the Chinese description clues are embedded that pertain to the origins of both Western medicine and the history of complementary and alternative medicine (CAM) as briefly described: “Disease has always been a great topic of concern in human society. From prayers and spells to the birth of medicine as a rational science, man has been able to develop all sorts of medical treatments to combat against different illnesses and ailments, because, as the Chinese proverb has it, ‘life is worth more than a thousand gold pieces.’ Towards the end of the Eastern Han (the 3rd century), typhoid was rampant in China, and the fatality rate was extremely high. Chang Chung-ching, with his extensive clinical experience, wrote the Treatise on Cold-Induced Febrile and Miscellaneous Diseases, and thereby established the foundations for ‘treatment based on differentiation of symptom-complex’ in traditional Chinese medicine. After that, as governments began setting up medical institutions and experiences of private doctors came to be valued, many important medicinal theories, treatments and much pharmaceutical knowledge were gradually organized systematically. Advancements in pharmacology were particularly notable. For example, the Newly-Revised Materia Medica issued by Emperor Kao-tsung of the T'ang dynasty in the 10th year of his reign (659) was the first pharmacological encyclopedia edited and published by the government, and a copy was taken to Japan by Japanese emissaries soon after its completion.” Why launch Evidence-based Complementary and Alternative Medicine (eCAM)? With this brief excursion into our history, it is appropriate to mention to those anxious to read our first issue what we are about. Once again a new journal is born, and in the spring when there is an awakening from a winter's sleep, a rejuvenation (reconstruction, renewal, renovation), a renaissance (rebirth, resurgence, revitalization, revival, reawakening). Many will greet this birth with mixed feelings. With numerous journals devoted to CAM and already flourishing, other readers will consider that it is outright nonsense to start yet another journal devoted to the same subject. Still a greater number of CAM practitioners and basic scientists of all types have agreed to serve on the Editorial Board and to support the aims of eCAM and are certain of the real need for this journal. We all share various depths of elation and cautious optimism, partly because we are doing something a bit unique and partly because of having to compete with other journals that are devoted exclusively to CAM, or where the approaches of the authors are such that their manuscripts fit equally well into more established biomedical journals. In contrast to these elusive feelings, we also harbor the committed and strong belief that this new journal, eCAM, will flourish by means of imagination, scientific rigor and cooperative enthusiasm. All disciplines have beginnings met with enthusiasm by founders who must be, of necessity, loyalists—essential to protect against the onslaught of skepticism that always seems to occur when a new movement begins. As a developmental immunobiologist, interested in origins and foundations, I am of course steeped in the beginnings of modern immunology. Let us deal in a bit of musing juxtaposing immunology, science and CAM. Can eCAM Be Scientific? Lessons from Immunology According to Burnet (1): ‘The first objective in a serious approach to immunology should be to obtain a broad understanding, with a minimum of detail, of how immunology fits into the pattern of biology—of the way in which the immune system evolved, its function and coordination with other body systems, and its development from the embryo onwards. At the same time, such an outline should provide an adequate background for easy application of immunological ideas to the detail of practical immunological work in public health, clinical, and veterinary practice.’ Would it be possible to paraphrase this statement in the context of eCAM so that it reads: 'the first objective in a serious approach to complementary and alternative medicine (CAM) should be to obtain a broad understanding, with a minimum of detail, of how CAM fits into the pattern of biology—of the way in which the neuroendocrineimmune system evolved, its function and coordination with other body systems, and its development from the embryo onwards. At the same time, such an outline should provide an adequate background for easy application of CAM ideas to the detail of practical CAM work in public health, clinical and medical practice, and yet not stray far away from the very biology that under girds it. CAM is organismic, inclusive and not exclusive (2–4). So How do we Define CAM? So does any of this fit? Readers may be wondering just what is complementary medicine and what is alternative medicine? Several definitions may be offered based on different points of view and those in turn influenced by professional training, practice and, perhaps, the dictates of funding agencies. The discipline is a heterogeneous subject, to say the least, and it is unlikely that all the adherent disciplines that are sheltered by the umbrella of CAM will carry equal weight or influence or can be subjected to the same rigors of scientific inquiry. Some of these generalizations apply to all disciplines, including those sub-disciplines that fall under the aegis of the immunology umbrella. However, perhaps CAM is ripe for an infusion of empiricism. Modern immunology, like CAM, has its earliest roots in concerns for health and disease, but immunology never seemed to have been branded with the aura that often shrouds CAM. There were always a group of experimentalists and, perforce, the necessity to use animal models with which experimentation could be performed to test hypotheses. (To be clear and current on all aspects of the discipline, written by seasoned pioneers, readers are kindly referred to references 5–15 for further reading.) eCAM is a new concept that encompasses a wider and more inclusive medical science provided by online systems, and this more fully integrated concept comprises alternative, complementary and traditional medicine. At the beginning of the new century we recognize the tremendous success that modern medical science has achieved in the diagnosis and treatment of a number of diseases that were regarded as incurable for decades. Direct intervention through technological and molecular means has become possible. We are now recipients of the full benefit of the progress of modern medical sciences, and Western medicines in particular. Notwithstanding, we have also become aware that a comparative number of diseases still remain incurable by Western medicine, and that patients suffer without any hope of effective treatment. With all its successes, modern Western medicine also has limitations such as unbearable side effects, high medical costs, facilities that are not accessible to everyone, ethical problems, etc. Recently, alternative and complementary medicines, together with oriental and traditional medicines, have attracted much attention. This new interest includes aromatherapy and herbal medications, acupuncture, moxibustion, shiatsu and yoga. Often, however, these therapies have not been well defined. Some are simply based on legend or belief, while others are traditionally applied but without scientific evidence. The Need for eCAM The recent excessive commercialization of the health industry has left us puzzled as to what is true and what is false. Misleading information has been flooding into newspapers and magazines, and exaggerated advertisements can be seen everywhere (16–20). Yet among these there are credible accounts. This situation is particularly confusing for patients and doctors who seek remedies for heretofore undefined symptoms. Furthermore, since these treatments have not undergone strict testing, they are not always safe and the same drug may have different effects according to the individual patient and dosage. Complicated considerations are necessary for the application of practices such as those found in Chinese traditional medicine. Quality control is also important for the safe use of natural products. Due to the above difficulties, this realm of medicine has often been shut out of the serious journals of Western medicine. Our eCAM is launched in a desire to ameliorate this situation, by encouraging the publication of original scientific papers based on sound scientific guidelines, but without prejudice against the possible efficacy of these new and ancient treatments. A new international journal seeks to understand the sources and to encourage rigorous research in this new, yet ancient, world of complementary and alternative medicine. This international, rigorously peer-reviewed, journal seeks to apply scientific rigor to the study of CAM modalities, particularly traditional Asian healing systems. eCAM will emphasize health outcome, while documenting biological mechanisms of action and will be devoted to the advancement of science in the fields of basic research, clinical studies, methodology or scientific theory in diverse areas of biomedical sciences. With a base in Japan, eCAM will be the first true platform for scientists and practitioners in Asia. With Asia as their home, these contributors are familiar with the way many CAM techniques have been practiced for centuries, giving the journal a firm footing in the history and tradition of CAM. As with any truly important research, one must think radically; in other words, return to the radical or root of a question or practice. A greater understanding of thousands of years of history will give us greater access to the root and may well lead to exciting new discoveries. CAM is a worldwide phenomenon and eCAM will seek to be inclusive of new and old work all over the globe. With this same broad view, we will seek to make the journal truly inter-disciplinary with a varied editorial board on which philosophers and historians will be engaged in dialogue with biologists of all types and clinicians. It is our hope that the two bases, one in the east and the other in the West, especially at UCLA, will be gathering places for information and that our combined efforts will bridge cultures as well as CAM and modern biomedicine. The Future and Impact of eCAM So where are we? We began in China in a historical context, laying a foundation for CAM and Western medicine with the inference that bridges could be built. By linking the scientific basis of CAM with another discipline that too was once fledgling, now free from lack of empiricism, a foundation of hope was laid and the suggestion of animal models and natural products inferred. According to Normile (10), there is a new face to traditional Chinese medicine. Asian governments hope that high-volume screening and rigorous clinical trials will unlock the secrets of ancient herbal remedies—and that the results will pass muster with Western scientists. According to Vickers (21), there appears to be exceptional and growing public enthusiasm for botanical, or ‘herbal’, medicines, especially amongst cancer patients. This has recently begun to be matched by increasing scientific attention. Quality control of botanicals poses significant challenges: small differences in genetics, soil, temperature, moisture and time of harvesting can lead to significant differences in the concentration of important constituents. Phase I and II methodology is also problematic: botanicals have low toxicity and are unlikely to cause rapid tumor regression. There is currently minimal regulation of botanical medicines. Turning to products from animals, particularly those from the sea, according to Haefner (22), in recent years marine natural product bioprospecting has yielded a considerable number of drug candidates. Most of these molecules are still in preclinical or early clinical development but some are already on the market, such as cytarabine, or are predicted to be approved soon, such as ET743 (Yondelis). Research into the ecology of marine natural products has shown that many of these compounds function as chemical weapons and have evolved into highly potent inhibitors of physiological processes in the prey, predators or competitors of the marine organisms that use them. Some of the natural products isolated from marine invertebrates have been shown, or are suspected, to be of microbial origin and this is now thought to be the case for the majority of such molecules. Marine microorganisms, whose immense genetic and biochemical diversity is only beginning to be appreciated, look likely to become a rich source of novel chemical entities for the discovery of more effective drugs. Lombrokinase is a product isolated from earthworms and sold on the market as a fibrinolytic agent (23). We must remember that these products are often associated with the immune systems of these creatures and that they evolved millions of years ago—thus their immune systems have been an effective survival strategy (24–30). And if it has worked for them, then humans should harness these as new-wave antibiotics or anticancer molecules, just to offer two biomedical (CAM) applications.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Drug Discovery, CAM and Natural Products

            Drug Discovery: Is it Relevant to Complementary and Alternative Medicine (CAM)? This editorial is related to two papers in volume 1 issue 2 of eCAM and to others concerned with molecules derived from terrestrial and marine species (1–15). These papers focus on natural products, especially those derived from the sea. Therefore, it is appropriate to apply the contributions of these papers, since they can offer a different perspective. It is, indeed, a matter of great coincidence that these papers are being published at a time when eCAM is making extensive efforts to highlight this subject, which occupies an important place in biomedicine and has enormous potential. This situation in which the focus, at least of publications, is on animal products, is in marked contrast to that of botanicals and herbals—qua plant-derived molecules, the available literature on which may be considered immense and sometimes focused in highly specialized journals. A recent issue of Science offers a veritable cornucopia of evidence concerned with new drugs, and it begins with an editorial entitled ‘Drug Discovery’ by Donald Kennedy Editor-in-Chief (16). This is followed by an introduction titled ‘Rethinking Drug Discovery (17) and a news essay, ‘Surviving the Blockbuster Syndrome; Orphan Drugs of the Future’ (18). Five reviews and viewpoints examine various aspects of molecular biology, organic chemistry and drug delivery systems (19–23). If one explores the enormous wealth in this issue of Science in science's next wave (), at least five presentations offer enormous potential for application (Bioprospecting beginning with ‘The Sweet Side of Venom and Practicing’ (24–28). This sojourn into the world of drug discovery is, in my opinion, an area pertinent to complementary and alternative medicine (CAM). It is not remote but is closely related, relevant and highly visible, not to mention that it has rapidly increasing potential for wider distribution and understanding. This appears almost inevitable with the practice of western medicine shifting somewhat or, at least, bridging the divide between western and eastern medicine through the intervention of CAM. After all, many of these claims of healing have deep and everlasting recorded roots in the ancient world, most notably throughout Asia. The challenge will be to subject certain claims to the rigors of science and demand that conclusions be evidence-based (12). Otherwise, CAM will be unable to withstand the criticism of biologists and, sometimes, that of educated and skeptical public. Historical Approaches to Antibiotics—A Template for CAM? There is a current trend of discovery and applications of bioactive agents from natural sources. According to Grabley and Thiericke (29), natural products account for 30% of international drug sales. Although recombinant proteins and peptides have been accounting for an increasing amount of sales, the superiority of low-molecular mass compounds in human disease therapy remains undisputed, mainly due to more favorable compliance and bioavailability. To meet the demand for the thousands of test samples that must be submitted for high-throughput screening (HTS), it is essential to successfully compete with the rigors of combinatorial chemistry by developing new strategies in natural product chemistry. HTS enables the testing of a large number of samples. Therefore, new concepts that can generate large collection of compounds that possess improved structural diversity are desirable. In the historical context and as a brief background, the discovery of antibiotics clearly ushered in a new approach for treating patients. It was entirely fortuitous—a byproduct of serendipity, a circumstance that scientists yearn for but from which they often do not benefit. In many respects, a template for CAM was being formed. Unlike this valuable discovery, and the currently emerging paradigm, the world of natural products has been awaiting more beneficial exploitation for several millennia. After all, what were people using as remedies long before Fleming's discovery of penicillin? In 1948, Japan was the third country, after the United States and the United Kingdom, to become self-sufficient in manufacturing penicillin (30). In addition to penicillin, there was an enormous amount of national exploratory research focusing on anti-infective, anti-cancer and agricultural antibiotics. Here is a summary, a brief chronology of discoveries. The first few antibiotics from Japan were colistin (1950), mitomycin C (1955), kanamycin (1957), bleomycin (1965), cefazolin (1969), amikacin (1972), piperacillin (1976), norfloxacin (1977), cefoperazone (1978), ofloxacin (1980), clarithromycin (1984), meropenem (1987), etc. Noteworthy antibiotic research on bioactive microbial products led to the discovery of agents beneficial to improving the human quality of life (QOL), e.g., pravastatin for hyperlipidemia and tacrolimus for atopic diseases. As an example among other nations, Japan will continue to maintain a high level of activity in exploratory research on beneficial chemotherapeutic agents during this century. The Japanese Society of Chemotherapy (JSC), established in 1953, has played a central role in evaluating novel agents including those introduced from other countries. The JSC is active in establishing guidelines for chemotherapy and in educating clinical scientists as well as evaluating chemotherapeutic agents both fundamentally and clinically. The Oceans are a Rich Source of Natural Products that are Potential Medicinals—Natural Product Formulations Available in Europe for Psychotropic Indications During the mid 20th century, the development of medical treatments for human disease was intimately connected with a variety of products derived largely from the plant kingdom (31). Despite recent advances in utilizing chemically synthetic approaches to drug design and sophisticated structure-activity analyses, there continues to exist a great requirement in medicine for novel compounds with unique action mechanisms. While several thousands of structural analogs have been synthesized and tested, numerous gaps remain in the therapeutic armamentarium for psychiatric illnesses. A majority of the new drugs marketed for psychotherapeutic indications have only served as incremental improvements on existing medications. Significant discoveries have resulted primarily from analyzing natural products. Several valuable drugs have been isolated from plant and animal sources; these include aspirin, morphine, reserpine (the first antipsychotic), almost all antibiotics, digitalis, and anti-cancer agents such as vincristine, vinblastine, and Taxol. Drugs from the Sea: Harvesting the Results of Aeons of Chemical Evolution According to Wallace (32), despite recent developments in combinatorial chemistry that can rapidly generate thousands of new chemicals, the pharmaceutical industry still relies heavily on a staggering array of undiscovered possibilities from the natural environment. These could lead to the discovery of novel compounds that will surely extend the boundaries of our chemical research efforts. The terrestrial environment has been mined for compounds for many years, with great success. Currently, promising compounds are being tapped from the world's oceans. Many of these chemicals are structurally complex, which challenges modern organic chemists with unlimited approaches to mimic the synthetic versatility of nature. In the future, these marine compounds are likely to yield entirely new classes of drugs which would be a valuable contribution to our ability to treat human disease. We are in need of such overtures, discoveries and innovations in the face of rising medical costs and the fact that a fraction of the general public (at least in the US) is underinsured and often disgruntled with modern-day, western medical practice. As we visualize a vaguely relevant situation of coexistence, a rather simple analogy is perhaps appropriate. Street markets are now offering complementary and alternative sources to the supermarket with its chilled atmosphere and speedy and efficient service. Perhaps we wish for something that has a long past and that offers, in many instances, equivalent or better service and assistance. CAM could possibly represent our street markets, whereas western medicine could be viewed as a super market. Clearly, this brief sojourn reveals that medicine benefits immensely from the rich pharmacopoeia-products of our terrestrial and aquatic environments—both plants and animals. Although most medicines are derived from terrestrial plants and animals, ecologists estimate the number of species in the marine environment to be 0.5–10 million. Most of these are still waiting to be discovered, opening neither a Pandora's box nor a can of worms but an unfathomable array of newer cures. Several questions may be posed in this new era of exploration: Why marine organisms such as invertebrates? (32). Can problems related to synthesis and supply of marine natural products of pharmacological interest be resolved? So far, most marine secondary products are cellular toxins. What are the limits of marine biodiversity and how rapidly is this biodiversity being lost? Is it possible to provide a rational basis for discovering useful marine natural products by understanding the ecological interactions of organisms that compete with each other for food and space? What are the evolutionary connections between secondary metabolites from the marine world and the signaling pathways within our own bodies? Clearly, the papers included in eCAM provide some of the answers.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Combination Effects of Herbs in a Multi-herbal Formula: Expression of Juzen-taiho-to's Immuno-modulatory Activity on the Intestinal Immune System

              Herbal formulas of traditional Japanese (Kampo), Chinese and Korean medicines usually comprise multiple herbs in a single formula. These medicines are expected to show their clinical effects by chemical, pharmacological and pharmaceutical combination effects of multi-herbs. However, little effort has been made so far to scientifically clarify the nature of such combination effects. Interestingly, for example, though a Kampo medicine Juzen-taiho-to (Shi-Quan-Da-Bu-Tang in Chinese) stimulates the immune functions of Peyer's patch cells, none of its single component herbs shows such activity. We thus examined the combination effect of herbs in the Juzen-taiho-to formula for the expression of its immuno-stimulating activity. Juzen-taiho-to, a composite formula of 10 herbs, has been generally considered to comprise two kinds of basic formula, each of which consists of four different herbs in addition to two others. The combinations of herbs based on these two basic formulas were evaluated for their stimulating activities on cytokine production from murine Peyer's patch cells both in vitro and ex vivo. Combined decoction of six among 10 herbs in Juzen-taiho-to is crucial for the expression of its stimulating activity on Peyer's patch cells. 3D-HPLC analysis of the ingredients in the fractions from the combined decoctions indicated that, in addition to quantitative changes of ingredients, alterations occur in their chemical composition by decoction of different herbs. The stimulating activity of Juzen-taiho-to on Peyer's patch cells results from the combination effect of its six essential component herbs. This combination effect is based on physicochemical interactions among the ingredients of the component herbs.
                Bookmark

                Author and article information

                Journal
                Evid Based Complement Alternat Med
                Evidence-based Complementary and Alternative Medicine
                Evidence-based Complementary and Alternative Medicine
                Oxford University Press
                1741-427X
                1741-4288
                June 2005
                : 2
                : 2
                : 125-127
                Affiliations
                Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California at Los Angeles Los Angeles, CA 90095-1763, USA
                Author notes
                For reprints and all correspondence: Edwin L. Cooper, PhD, ScD, Distinguished Professor, Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, CA 90095-1763, USA. Tel: +1-310-825-9567; Fax: +1-310-825-2224; E-mail: cooper@ 123456mednet.ucla.edu
                Article
                10.1093/ecam/neh094
                1142206
                15937551
                da89c443-73b3-44e3-bd0d-2863dc56f8a1
                © The Author (2005). Published by Oxford University Press. All rights reserved.

                The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@ 123456oupjournals.org

                History
                Categories
                Editorial

                Complementary & Alternative medicine
                Complementary & Alternative medicine

                Comments

                Comment on this article